Company

Novo Nordisk A/S

2023

Quick facts

3,831,000

Emissions (ton CO₂e)

34,839.15

Revenue (M USD)

109.96

Intensity (t CO₂e / M USD)

Ambition & Development

In 2023, Novo Nordisk A/S reported a total of 3,831,000 ton CO₂e, and a net revenue of 34,839.15 M USD, resulting in a emissions intensity of 109.96 t CO₂e / M USD.

Targets

Base year:

2018

Target year:

2030

Reduction:

Classification:

1.5°C

Danish multinational pharmaceutical company Novo Nordisk A S commits to reduce scope 1 and 2 emissions 100% by 2030 from a 2018 base-year.

Source: Science Based Target initative

Emissions, Revenue & Intensity

Emissions, Target & Trend

Revenue	2021	2022	2023
Net Revenue (M USD)	21,204.48	27,109.35	34,839.15
Revenue Source

Emissions Overview	2021	2022	2023
Total Emissions - Market Based (t CO₂e)	93,000	2,510,000	3,831,000
Emissions Intensity (t CO₂e / M USD)	4.39	92.59	109.96
Cradle-to-gate Intensity (t CO₂e / M USD)	4.39	91.11	108.38

Emissions Details	2021	2022	2023
Scope 1	77,000	76,000	78,000
Scope 2
Scope 2 - Location Based
Scope 2 - Market Based	16,000	16,000	15,000
Scope 2 - Not specified
Scope 3		2,418,000	3,738,000
Upstream Emissions
1. Purchased goods and services		1,473,000	2,067,000
2. Capital goods		614,000	1,315,000
3. Fuel- and energy-related activities		55,000	56,000
4. Upstream transportation and distribution		123,000	113,000
5. Waste generated in operations		5,000	6,000
6. Business travel		73,000	83,000
7. Employee commuting		35,000	43,000
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution		37,000	52,000
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products		3,000	3,000
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions	93,000	2,510,000	3,831,000
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0